Hormonal treatment in cancer of the prostate
Boccon-Gibod, L.
La Revue du Praticien 37(7): 386-390
1987
ISSN/ISBN: 0035-2640 PMID: 3823774 Document Number: 295370
Document emailed within 1 workday
Related Documents
De Voogt, H.J. 1986: Prostate cancer; hormonal treatment in a new stage? Nederlands Tijdschrift Voor Geneeskunde 130(17): 766-768Faris, G.; Stein, A.; Lurie, A. 1993: Hormonal treatment of advanced prostate cancer Harefuah 124(1): 35-40
Autorino, R.; Di Lorenzo, G.; D'Armiento, F.P.; Mignogna, C.; Cindolo, L.; De Sio, M.; Perdona, S.; De Fortuna, E.; Salzano, L.; De Placido, S.; D'Armiento, M. 2005: Neuroendocrine differentiation after neoadjuvant hormonal treatment in prostate cancer Minerva Urologica e Nefrologica 57(4): 319-324
Viollet, G.; Robin, M.; Colombeau, P.; Ciblac, G. 1977: Apropos of diagnosis, prognosis and hormonal treatment of cancer of the prostate Journal d'Urologie et de Nephrologie 83(10-11): 896-900
Jager, P.L.; Mensink, H.J.; van den Bergh, A.C.; Piers, D.A. 1999: A strontium-89 injection: a simple treatment of painful bone metastases in patients with prostate cancer unresponsive to hormonal treatment Nederlands Tijdschrift Voor Geneeskunde 143(19): 969-973
Hakariya, T.; Sakai, H. 2016: Efficacy and problems of new hormonal agents for the treatment of castration resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 137-142
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Utomo, N.B.; Mochtar, C.A.; Umbas, R. 2012: Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors Acta Medica Indonesiana 44(1): 10-15
Kraljić, I.; Tarle, M. 1987: Evaluation of endocrine therapy of prostate cancer by assessing tumor markers and hormone parameters. Hormonal "cross-over" treatment of false endocrine independent tumors Progress in Clinical and Biological Research 243b: 521-525
Trachtenberg, J. 1994: State-of-the-art hormonal management of prostate cancer Canadian Journal of Urology 1(3): 49-52
Miki, T.; Kamoi, K. 2001: Neoadjuvant hormonal therapy for prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(7): 927-933
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Brucić, L.J.; Juretić, A.; Solarić, M.; Bisof, V.; Basić-Koretić, M.; Rakusić, Z.; Santek, F. 2012: Hormonal therapy of prostate cancer: are there any dilemmas left? Lijecnicki Vjesnik 134(3-4): 94-104
Song, H.-z.; Chen, L.-b. 2007: Advances in researches on hormonal refractory prostate cancer Zhonghua Nan Ke Xue 13(1): 57-60
Smith, J.A. 1988: Hormonal therapy of prostate cancer: current concepts and future prospects Clinical Therapeutics 10(3): 281-286
Habib, F.K.; Chisholm, G.D. 1984: Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate Archivos Espanoles de Urologia 37(Suppl 2): 751-759
Nagae, H.; Sato, T.; Nagata, M.; Un-no, T.; Mugiya, S.; Ichijo, K. 2001: Local staging with magnetic resonance imaging after neoadjuvant hormonal therapy for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 47(9): 615-618
Kitamura, K.; Shirato, H.; Shimizu, S.; Miyasaka, K.; Demura, T.; Shinohara, N.; Harabayashi, T. 2000: Real-time tumor-tracking radiotherapy combined with neoadjuvant hormonal therapy for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 326-329
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442